Breaking News
June 20, 2018 - Why are vaccines less effective in the developing world?
June 20, 2018 - Study opens new window into cellular events that occur in the brain during absence seizures
June 20, 2018 - Humana and Walgreens to provide easier access to primary care and other services for seniors
June 20, 2018 - ANU research could help find life in Mars and other planets
June 20, 2018 - Multidisciplinary Human-Focused Research
June 20, 2018 - New study finds increase in use of alternative medicines among children
June 20, 2018 - Elevated NT-proBNP Found to Up Cardiovascular Risk in T2DM
June 20, 2018 - Genetics Home Reference: White-Sutton syndrome
June 20, 2018 - Canadian team reports success in transplanting hepatitis C organs
June 20, 2018 - Separating migrant children from parents at US border tantamount to child abuse
June 20, 2018 - Study finds more information about how gene linked to ASD affects the brain
June 20, 2018 - Floppy eyelids linked to sleep apnea
June 20, 2018 - Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson
June 20, 2018 - KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug response assay
June 20, 2018 - Study finds growing support to allow pharmacists to write prescriptions
June 20, 2018 - LabConnect collaborates with Symphony to support clinical research industry
June 20, 2018 - Italian innovative SME receives 2.5 million Euro from RedSeed Ventures
June 20, 2018 - AHA: Kids Can Drown Quickly and Silently, So Prevention Is Key
June 20, 2018 - Continuous glucose monitors proven cost-effective, add to quality of life for diabetics
June 20, 2018 - Researchers use droplet-sized ‘miniecosystems’ to test therapeutic potential of molecules
June 20, 2018 - New approach could provide objective and easy-to-obtain measure of dietary adherence
June 20, 2018 - Dual-therapy approach can help boost motor recovery in stroke victims
June 20, 2018 - ‘Miracle treatment’ long-term success for babies with diabetes
June 20, 2018 - Rheumatoid Arthritis patients with depression have increased risk of disease flare
June 20, 2018 - NTU launches new research centers to prevent and treat diseases affecting Singaporeans
June 20, 2018 - Merck enters into agreement with HistoCyte Laboratories to distribute cell line reference products
June 20, 2018 - Researchers examine risk factors for opioid dependence in patients undergoing surgery for DS
June 20, 2018 - Study finds substantial variation in cardiovascular risk across India
June 20, 2018 - Kidney donation among carefully-selected older adults poses minimal risks
June 20, 2018 - Effects of atrial fibrillation can be reduced or reversed by losing weight
June 20, 2018 - Allergan’s Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy and Safety in Episodic Migraine Prevention in a Phase 2b/3 Clinical Trial
June 20, 2018 - The novel insights of proteoglycans in mineralized tissues
June 20, 2018 - Scientists shed light on key aspect of healthy cell division
June 20, 2018 - Circulating bone turnover markers not linked to hip fracture risk, shows study
June 20, 2018 - Scientists obtain key information about proteins from single human cells
June 20, 2018 - Scientists identify novel genes linked with infantile forms of schizophrenia
June 20, 2018 - Low-dose aspirin could help pregnant women with high blood pressure avoid a dangerous condition
June 20, 2018 - Unusual gene provides novel insight into how the brain wires itself
June 20, 2018 - Study finds IV acetaminophen to be no more effective than oral counterpart for colectomy patients
June 20, 2018 - MAARA to celebrate its 50th anniversary with lecture titled ‘The Future of Asthma’
June 20, 2018 - Administration eases way for small businesses to buy insurance in bulk
June 20, 2018 - High-Quality Diet May Decrease Mortality Risk in Cancer Survivors
June 20, 2018 - JAMA editorial on ECG screening and cardiac risks
June 20, 2018 - Study hints at benefits of lifestyle interventions in reducing dementia risk
June 20, 2018 - Low blood levels of vitamin D linked to increased risk of interstitial lung disease
June 20, 2018 - Simple cognitive task after brain injury improves memory function, study finds
June 20, 2018 - Clinical trial targets metastatic colorectal cancer with new combination therapy
June 20, 2018 - Researchers discover pesticide-free way to limit mosquitoes and reduce spread of West Nile virus
June 20, 2018 - Persistent psychological stress contributes to development and progression of vision loss
June 20, 2018 - Study introduces novel strategy to obtain reasonable drug cost estimates for cost-effectiveness analyses
June 20, 2018 - Does Salt Water Help Your Cut? And Other Health Myths of Summer
June 20, 2018 - Scientists help identify genetic markers for prostate cancer in global DNA download
June 19, 2018 - Common ingredient in toothpaste and hand wash could contribute to antibiotic resistance
June 19, 2018 - WHO launches multiyear campaign to eliminate use of trans fat
June 19, 2018 - Scientists could build better drugs by learning from bacteria-derived molecules
June 19, 2018 - Comparative silence between firing spikes of neurons reveals what they are really up to
June 19, 2018 - JAK inhibitors associated with aggressive lymphoma
June 19, 2018 - SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis
June 19, 2018 - Hypnosis may help reduce fear, anxiety in children undergoing treatment for cancer
June 19, 2018 - Scientists point to potentially promising treatment target for deadly brain cancers
June 19, 2018 - After opioid overdose, only 30 percent get medicine to treat addiction
June 19, 2018 - Patients with mild Alzheimer’s disease over age 65 continue to derive benefit from DBS-f treatment
June 19, 2018 - Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis
June 19, 2018 - Paratek Presents New Analysis from Combined Phase 3 Skin Infection Studies Highlighting Efficacy of Omadacycline in Treating Drug Resistant S. aureus
June 19, 2018 - Autism is not linked to eating fish in pregnacy
June 19, 2018 - Scientists create universal assembly method to enhance cancer therapy and diagnostics
June 19, 2018 - Follow-up study confirms success of physiological test for autism
June 19, 2018 - FDA provides guidance on Novus Therapeutics’ development path for OP-02 to treat otitis media
June 19, 2018 - Scientists discover new mechanism controlling multiple sclerosis risk
June 19, 2018 - Award granted to Neem Biotech to develop antimicrobial intervention for chronic lung infections
June 19, 2018 - Study finds combined risk of death and developing cancer to be lowest in light drinkers
June 19, 2018 - Novel app teaches users how to stop life-threatening bleeding and save lives
June 19, 2018 - Single blood sample can provide adequate confirmation of diabetes
June 19, 2018 - New stimulation method increases hope for improving disorders of consciousness
June 19, 2018 - FDA Issues Complete Response Letter for Duobrii (halobetasol propionate and tazarotene) Lotion
June 19, 2018 - Defining the biology of autism
June 19, 2018 - Researchers use optogenetics to shape tissues
June 19, 2018 - Scientists discover genetic causes underlying group of related infant cancers
June 19, 2018 - Innovative digital home testing kit benefits patients with kidney conditions
June 19, 2018 - New guidance on selection and evaluation of wearable devices for use in regulatory clinical trials
Scientists reveal mechanisms that may help preterm infants extend nephron development window

Scientists reveal mechanisms that may help preterm infants extend nephron development window

image_pdfDownload PDFimage_print

Nephrons are the microscopic blood-filtering units inside our kidneys that convert waste products into urine, regulate our electrolyte levels and our blood pressure.

Most of us are born with about 1 million nephrons, all of which form in the womb between weeks 25 to 36 of gestation. Unfortunately, the nephron formation process can be interrupted when babies are born preterm, which places them at higher risk of developing kidney disease later in life.

Now a study led by scientists at Cincinnati Children’s reveals one mechanism involved in regulating when nephron formation ends. The discovery, based on mouse models, suggests that intervention during pregnancy or after preterm birth could extend nephron development. If translated to clinical practice years from now, the result could be reduced need for kidney transplants and fewer deaths from kidney disease.

Findings were posted online today in the journal PNAS.

The paper is the latest advance by scientists at Cincinnati Children’s who are trying to reduce preterm birth by addressing environmental factors, understanding genetic drivers, and exploring the mechanisms that regulate complications.

“All the nephrons you or I have were generated while we were in our mother’s uterus. Prematurity terminates this process too early. As a result, adults that were born prematurely are at high risk for hypertension, heart disease and end stage renal disease,” says Raphael Kopan, PhD, Director of the Division of Developmental Biology at Cincinnati Children’s, and senior author of today’s study. “The question we tried to address is how we generate the specific number of nephrons we have as adults, and how can we increase this number in premature babies.”

Can a closing window of development be propped open?

By studying how mice control their nephron numbers, the researchers discovered that a protein called hamartin plays a central role in shutting down the nephron formation process. Until now, this protein was known primarily as a factor involved in tuberous sclerosis complex, a rare genetic disease that causes benign tumors to grow in the brain, kidneys, heart, and other organs. In this study, when mice were bred to produce reduced amounts of hamartin, their kidneys developed 25 percent more nephrons than a control group.

However, when bred to produce no hamartin at all, the mice developed fatal kidney defects. These results were seen in mice with two different genetic backgrounds, suggesting that hamartin function did not depend upon the method the research team used to reduce its level.

“This study provides important new information that will improve outcomes for all babies bornprematurely,” says Louis Muglia, MD, PhD, Co-Director of the Perinatal Institute at Cincinnati Children’s and Director of the Center for Prevention of Preterm Birth. “Optimizing pregnancy outcomes is a central focus shared by the basic scientists and clinicians in the Perinatal Institute, and this work reflects that shared commitment.

More study needed before people can benefit

From affected families to society at large, the health impact of preterm birth remains a major concern. Overall, about one in 10 infants are born prematurely (before 37 weeks) in the U.S. That’s about 387,000 births a year, according to the U.S. Centers for Disease Control and Prevention. Of those, nearly 109,000 are considered “early” preterm births (before 34 weeks). This group faces the highest risk of complications from interrupted kidney development.

As they grow up, many of those babies join the ranks of more than 8 million Americans affected by chronic kidney disease, including more than 100,000 who begin dialysis each year while awaiting a kidney transplant.

At first glance, today’s findings suggest that the hamartin protein would be a prime target for a medication to protect kidney development. However, in people, directly reducing hamartin production would likely cause tuberous sclerosis.

“We have discovered the tip of the iceberg,” Kopan says. “We are hoping that the mechanism hamartin acts through to regulate nephron numbers will contain druggable targets.”

If a safe drug can be developed, treatment would need to be provided shortly after a preterm infant is delivered.

“We never make another nephron after we are 36 weeks old,” Kopan says. “It would be necessary to target at-risk premature babies to try to prolong their nephron-generating window.”

So far, no diagnostic test exists that can determine if a developing fetus or newborn preterm baby has a nephron shortage. But several research groups around the world are studying how to use MRI scans to measure nephron supply. That work currently is focused on adults, but if proven safe, will eventually become applicable in newborns.

Science builds upon Cradle Cincinnati work

Today’s study is one of many efforts underway at Cincinnati Children’s to address the problem of prematurity. Cincinnati Children’s is a leading partner in Cradle Cincinnati, a community-wide collaboration to reduce high rates of preterm birth and infant mortality in Hamilton County. The organization has already helped reduce infant deaths through initiatives to manage factors that contribute to preterm birth, such as promoting smoking cessation, waiting at least a year between pregnancies, and safe sleep practices.

Until recently, not much was known about how genetic factors might play a role in premature birth. In a breakthrough study last year, scientists here collaborated with the company 23andMe in a large-scale genetic study. They discovered six genomic locations that show strong potential to affect birth timing.

It remains to be seen how that discovery will lead to improved treatments. But together with Cradle Cincinnati’s programs and today’s study, research is helping identify ways to reduce some of the problems associated with premature birth, Muglia says.

Source:

https://www.cincinnatichildrens.org/news/release/2018/preterm-infants-kidneys

Tagged with:

About author

Related Articles